Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
multivalent reassorted attenuated live rotavirus vaccine (vero cell, oral)
- Development stage
- Preclinical
- Lead developer
- Shandong Yidu Biotechnology
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
Multivalent reassorted attenuated live rotavirus vaccine is an oral vaccine candidate developed by Shandong Yidu Biotechnology for the prevention of rotavirus-induced gastroenteritis. The vaccine utilizes human-origin reassortant rotavirus strains acquired from the U.S. National Institutes of Health (NIH) in 2018 and is produced using Vero cell culture technology. As a multivalent formulation, it is designed to provide broader protection against multiple rotavirus serotypes compared to monovalent alternatives by inducing both mucosal and systemic immunity. The project is currently in the preclinical stage of development.
- Other names
- 口服多价重配轮状病毒减毒活疫苗(Vero细胞)Muti-Valent Reassorted Attenuated Live Rotavirus Vaccine, Oral, Vero Cell
Beyond the preview
Go deeper on multivalent reassorted attenuated live rotavirus vaccine (vero cell, oral).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on multivalent reassorted attenuated live rotavirus vaccine (vero cell, oral).